Up a level |
Ramanan, AV, Dick, AD, Jones, AP, McKay, A, Williamson, PR ORCID: 0000-0001-9802-6636, Compeyrot-Lacassagne, S, Hardwick, B, Hickey, H, Hughes, D, Woo, P et al (show 3 more authors)
(2016)
ADALIMUMAB IN COMBINATION WITH METHOTREXATE FOR THE TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS ASSOCIATED UVEITIS: THE SYCAMORE TRIAL.
.
Ramanan, AV, Dick, AD and Beresford, MW ORCID: 0000-0002-5400-9911
(2017)
Adalimumab for Uveitis in Juvenile Idiopathic Arthritis.
The New England journal of medicine, 377 (8).
pp. 789-790.
Horton, S, Jones, AP, Guly, CM, Hardwick, B, Beresford, MW ORCID: 0000-0002-5400-9911, Lee, RWJ, Dick, AD and Ramanan, AV
(2019)
Adalimumab in juvenile-idiopathic arthritis-associated uveitis (JIA-U): 5-year follow-up of the Bristol participants of the SYCAMORE trial.
American journal of ophthalmology, 207.
pp. 170-174.
Ramanan, AV, Dick, AD, Jones, AP, McKay, A ORCID: 0000-0003-1312-8911, Williamson, PR ORCID: 0000-0001-9802-6636, Compeyrot-Lacassagne, S, Hardwick, B, Hickey, H ORCID: 0000-0003-0467-0362, Hughes, D ORCID: 0000-0001-8247-7459, Woo, P et al (show 4 more authors)
(2017)
Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis.
New England Journal of Medicine, 376 (17).
pp. 1637-1646.
Massias, JS, Smith, EMD, Al-Abadi, E, Armon, K, Bailey, K, Ciurtin, C, Davidson, J, Gardner-Medwin, J, Haslam, K, Hawley, DP et al (show 14 more authors)
(2020)
Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups.
LUPUS, 29 (5).
pp. 474-481.
Smith, EMD, Yin, P, Jorgensen, AL ORCID: 0000-0002-6977-9337 and Beresford, MW ORCID: 0000-0002-5400-9911
(2018)
Clinical predictors of active LN development in children - evidence from the UK JSLE Cohort Study.
LUPUS, 27 (13).
pp. 2020-2028.
Ramanan, AV, Hampson, LV, Lythgoe, H, Jones, AP, Hardwick, B, Hind, H, Jacobs, B, Vasileiou, D, Wadsworth, I, Ambrose, N et al (show 11 more authors)
(2019)
Defining consensus opinion to develop randomised controlled trials in rare diseases using Bayesian design: An example of a proposed trial of adalimumab versus pamidronate for children with CNO/CRMO.
PLOS ONE, 14 (6).
e0215739-.
Smith, EMD
(2016)
Developing a Lupus Nephritis urinary biomarker panel in children for use in a clinical trial.
PhD thesis, University of Liverpool.
McCann, LJ, Pilkington, CA, Huber, AM, Ravelli, A, Appelbe, D, Kirkham, JJ ORCID: 0000-0003-2579-9325, Williamson, PR ORCID: 0000-0001-9802-6636, Aggarwal, A, Christopher-Stine, L, Constantin, T et al (show 13 more authors)
(2018)
Development of a consensus core dataset in juvenile dermatomyositis for clinical use to inform research.
Annals of the rheumatic diseases, 77 (2).
pp. 241-250.
Ambrose, N, Morgan, TA, Galloway, J, Ionnoau, Y, Beresford, MW ORCID: 0000-0002-5400-9911 and Isenberg, DA
(2016)
Differences in disease phenotype and severity in SLE across age groups.
LUPUS, 25 (14).
pp. 1542-1550.
Donohue, SJ, Midgley, A, Davies, JC, Wright, RD ORCID: 0000-0002-7606-2297, Bruce, I, Beresford, MW ORCID: 0000-0002-5400-9911 and Hedrich, CM ORCID: 0000-0002-1295-6179
(2020)
Differential analysis of serum and urine S100 proteins in juvenile-onset systemic lupus erythematosus (jSLE).
CLINICAL IMMUNOLOGY, 214.
108375-.
Smith, EMD, Jorgensen, AL ORCID: 0000-0002-6977-9337 and Beresford, MW ORCID: 0000-0002-5400-9911
(2017)
Do classic blood biomarkers of JSLE identify active lupus nephritis? Evidence from the UK JSLE Cohort Study.
Lupus, 26 (11).
pp. 1212-1217.
Lythgoe, H, Morgan, T, Heaf, E, Lloyd, O and Beresford, MW ORCID: 0000-0002-5400-9911
(2016)
EVALUATION OF THE ACR AND SLICC CLASSIFICATION CRITERIA IN JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS: A LONGITUDINAL ANALYSIS.
.
Lythgoe, H, Morgan, T, Heaf, E, Lloyd, O, Al-Abadi, E, Armon, K, Bailey, K, Davidson, J, Friswell, M, Gardner-Medwin, J et al (show 10 more authors)
(2017)
Evaluation of the ACR and SLICC classification criteria in juvenile-onset systemic lupus erythematosus: a longitudinal analysis.
LUPUS, 26 (12).
pp. 1285-1290.
Lythgoe, H, Price, V, Beresford, MW, Peak, M and Hawcutt, D ORCID: 0000-0002-8120-6507
(2016)
G90(P) Research exposure for UK junior paediatric trainees.
.
Hedrich, CM ORCID: 0000-0002-1295-6179, Beresford, MW ORCID: 0000-0002-5400-9911, Dedeoglu, F, Hahn, G, Hofmann, SR, Jansson, AF, Laxer, RM, Miettunen, P, Morbach, H, Pain, CE ORCID: 0000-0003-4965-3259 et al (show 8 more authors)
(2023)
Gathering expert consensus to inform a proposed trial in chronic nonbacterial osteomyelitis (CNO).
CLINICAL IMMUNOLOGY, 251.
109344-.
Smith, EMD, Lewandowski, LB, Jorgensen, AL ORCID: 0000-0002-6977-9337, Phuti, A, Nourse, P, Scott, C and Beresford, MW ORCID: 0000-0002-5400-9911
(2018)
Growing international evidence for urinary biomarker panels identifying lupus nephritis in children - verification within the South African Paediatric Lupus Cohort.
LUPUS, 27 (14).
pp. 2190-2199.
Dimou, P, Midgley, A, Peak, M ORCID: 0000-0003-1909-3211, Wright, RD ORCID: 0000-0002-7606-2297 and Beresford, MW ORCID: 0000-0002-5400-9911
(2016)
INVESTIGATING THE NEUTROPHIL-MACROPHAGE INTERPLAY IN JUVENILE LUPUS NEPHRITIS PATHOGENESIS.
.
Patel, M, Oni, L ORCID: 0000-0002-1532-2390, Midgley, A, Smith, E, Tullus, K, Marks, SD, Jones, CA, Pilkington, C and Beresford, MW ORCID: 0000-0002-5400-9911
(2016)
Increased concentration of plasma TNFR1 and TNFR2 in paediatric lupus nephritis.
LUPUS, 25 (9).
pp. 1040-1044.
Midgley, A and Beresford, MW ORCID: 0000-0002-5400-9911
(2016)
Increased expression of low density granulocytes in juvenile-onset systemic lupus erythematosus patients correlates with disease activity.
LUPUS, 25 (4).
pp. 407-411.
Oni, L ORCID: 0000-0002-1532-2390, Beresford, MW ORCID: 0000-0002-5400-9911, Witte, D, Chatzitolios, A, Sebire, N, Abulaban, K, Shukla, R, Ying, J and Brunner, HI
(2017)
Inter-observer variability of the histological classification of lupus glomerulonephritis in children.
LUPUS, 26 (11).
pp. 1205-1211.
Smith, EMD, Jorgensen, AL ORCID: 0000-0002-6977-9337, Midgley, A, Oni, L ORCID: 0000-0002-1532-2390, Goilav, B, Putterman, C, Wahezi, D, Rubinstein, T, Ekdawy, D, Corkhill, R et al (show 6 more authors)
(2017)
International validation of a urinary biomarker panel for identification of active lupus nephritis in children.
Pediatric Nephrology, 32 (2).
pp. 283-295.
Hedrich, CM ORCID: 0000-0002-1295-6179, Smith, EMD and Beresford, MW ORCID: 0000-0002-5400-9911
(2018)
Juvenile-onset systemic lupus erythematosus (jSLE) - Pathophysiological concepts and treatment options.
Best Practice and Research: Clinical Rheumatology, 31 (4).
pp. 488-504.
Smith, EMD, Eleuteri, A ORCID: 0000-0003-0718-6672, Goilav, B, Lewandowski, L, Phuti, A, Rubinstein, T, Wahezi, D, Jones, CA, Marks, SD, Corkhill, R et al (show 6 more authors)
(2019)
A Markov Multi-State model of lupus nephritis urine biomarker panel dynamics in children: Predicting changes in disease activity.
CLINICAL IMMUNOLOGY, 198.
pp. 71-78.
Oni, L ORCID: 0000-0002-1532-2390, Hawcutt, DB ORCID: 0000-0002-8120-6507, Turner, MA ORCID: 0000-0002-5299-8656, Beresford, MW ORCID: 0000-0002-5400-9911, McWilliam, S ORCID: 0000-0002-0509-7425, Barton, C, Park, BK ORCID: 0000-0001-8384-824X, Murray, P, Wilm, B ORCID: 0000-0002-9245-993X, Copple, I ORCID: 0000-0003-4101-1913 et al (show 4 more authors)
(2017)
Optimising the use of medicines to reduce acute kidney injury in children and babies.
Pharmacology and Therapeutics, 174.
pp. 55-62.
Smith, Emd, Al-Abadi, E, Armon, K, Bailey, K, Ciurtin, C, Davidson, J, Gardner-Medwin, J, Haslam, K, Hawley, D, Leahy, A et al (show 13 more authors)
(2019)
Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritis.
Lupus, 28 (5).
p. 961203319836712.
Ramos-Martín, V, Neely, MN, McGowan, P, Siner, S, Padmore, K, Peak, M ORCID: 0000-0003-1909-3211, Beresford, MW ORCID: 0000-0002-5400-9911, Turner, MA ORCID: 0000-0002-5299-8656, Paulus, S ORCID: 0000-0002-0703-9114 and Hope, WW ORCID: 0000-0001-6187-878X
(2016)
Population pharmacokinetics and pharmacodynamics of teicoplanin in neonates: making better use of C-reactive protein to deliver individualized therapy.
The Journal of antimicrobial chemotherapy, 71 (11).
pp. 3168-3178.
Ramos-Martin, V, Neely, MN, Padmore, K, Peak, M ORCID: 0000-0003-1909-3211, Beresford, MW ORCID: 0000-0002-5400-9911, Turner, MA ORCID: 0000-0002-5299-8656, Paulus, S ORCID: 0000-0002-0703-9114, Lopez-Herce, J and Hope, WW ORCID: 0000-0001-6187-878X
(2017)
Tools for the Individualized Therapy of Teicoplanin for Neonates and Children.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 61 (10).
e00707-e00717.
Beresford, MW ORCID: 0000-0002-5400-9911, Kearsley-Fleet, L, Sampath, S, McCann, L, Baildam, E, Davies, R, De Cock, D, Foster, HE, Southwood, TR, Thomson, W et al (show 1 more authors)
(2018)
Use and Effectiveness of Rituximab in Children with Juvenile Idiopathic Arthritis in a Real-World Cohort Study in the United Kingdom.
Rheumatology (Oxford).
Attar, SG, Poustie, VJ, Hawcutt, DB ORCID: 0000-0002-8120-6507, Oni, L ORCID: 0000-0002-1532-2390, Beresford, MW ORCID: 0000-0002-5400-9911 and Pirmohamed, M ORCID: 0000-0002-7534-7266
(2019)
Working together to deliver stratified medicine research effectively.
British Medical Bulletin, 129 (1).
pp. 107-116.
Peterknecht, E, Keasey, MP and Beresford, MW ORCID: 0000-0002-5400-9911
(2018)
The effectiveness and safety of biological therapeutics in juvenile-onset systemic lupus erythematosus (JSLE): a systematic review.
LUPUS, 27 (13).
pp. 2135-2145.